Browse studies
Find your next paid study
76 recruiting studies matching your filters
Phase 1
Phase 1b Randomized, Double Blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 in Patients With Atopic Dermatitis and Psoriasis
The goal of this clinical trial is to study the drug LPX-TI641 in patients with atopic dermatitis and psoriasis. We will compare the safety and tolerability of…
Atopic Dermatitis (AD)Psoriasis (PsO)
Estimated
~$10 – $8,750
LAPIX Therapeutics Inc.NCT06982352
Phase 2
A Multicenter Open-Label Interventional Biomarker Study of Lutikizumab in Adult Subjects With Moderate-to-Severe Hidradenitis Suppurativa or Adult Subjects With Moderate-to-Severe Atopic Dermatitis
Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such …
Hidradenitis SuppurativaAtopic Dermatitis
Estimated
~$10 – $7,500
AbbVieNCT06524635
Longitudinal "Real-World" Changes in Skin Microbial Ecology in Atopic Dermatitis (AD) and Psoriasis (PS) Patients
Everybody's skin has bacteria that normally lives on it. Previous research has shown that people with eczema (or atopic dermatitis \[AD\]) have much higher con…
Atopic DermatitisPsoriasisHealthy
Estimated
~$10 – $750
University of RochesterNCT04170244
Phase 4
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Our hypothesis is that S. aureus skin decolonization in atopic dermatitis reduces disease severity and favorably alters the function and gene expression of epi…
Atopic Dermatitis
Estimated
~$10 – $6,250
Boston Children's HospitalNCT06397781